Nonlinear Mixed effect models are often used to describe population pharmacokinetics (PK) and Pharmacodynamics (PD) and play an important part of drug development both from regulatory and industry point of view. However, they can be time consuming and computationally expensive to develop. This thesis is a part of a larger collaboration between Uppsala University and two pharmaceutical companies, with the aim to develop a suite of software that can automate the model building process with more efficiency. One aspect that is important during the model building process is to detect how much the population parameter estimates are influenced by particular individuals. The results of this might lead to reconsideration of the model structure, as w...
The application of machine learning (ML) has shown promising results in precision medicine due to it...
Background: The dose individualization by therapeutic drug monitoring (TDM) can be improved if popul...
Objective: Metabolic syndrome (MetS) is an important side effect of second-generation anti-psychotic...
Nonlinear Mixed effect models are often used to describe population pharmacokinetics (PK) and Pharma...
Artificial Intelligence Lab, Department of MIS, University of ArizonaThis research examined the appl...
One of the objectives of Pharmacometry (PMX) population modeling is the identification of significan...
Pharmacometrics modeling encompasses both pharmacokinetics (PK) and pharmacodynamics (PD) data to qu...
Several machine learning techniques were evaluated for the prediction of parameters relevant in phar...
Population PK models aim to describe the change in drug concentration over time for a specific popul...
Summary: Forecasting pharmacokinetics (PK) for individual patients is a fundamental problem in clini...
Machine learning (ML) opens new perspectives in identifying predictive factors of efficacy among a l...
Abstract The gold‐standard approach for modeling pharmacokinetic mediated drug–drug interactions is ...
© 2022 by the authors.Pharmacometrics is a multidisciplinary field utilizing mathematical models of ...
Abstract We developed a method to apply artificial neural networks (ANNs) for predicting time‐series...
This work presents a pharmacodynamic population analysis in chronic renal failure patients using Art...
The application of machine learning (ML) has shown promising results in precision medicine due to it...
Background: The dose individualization by therapeutic drug monitoring (TDM) can be improved if popul...
Objective: Metabolic syndrome (MetS) is an important side effect of second-generation anti-psychotic...
Nonlinear Mixed effect models are often used to describe population pharmacokinetics (PK) and Pharma...
Artificial Intelligence Lab, Department of MIS, University of ArizonaThis research examined the appl...
One of the objectives of Pharmacometry (PMX) population modeling is the identification of significan...
Pharmacometrics modeling encompasses both pharmacokinetics (PK) and pharmacodynamics (PD) data to qu...
Several machine learning techniques were evaluated for the prediction of parameters relevant in phar...
Population PK models aim to describe the change in drug concentration over time for a specific popul...
Summary: Forecasting pharmacokinetics (PK) for individual patients is a fundamental problem in clini...
Machine learning (ML) opens new perspectives in identifying predictive factors of efficacy among a l...
Abstract The gold‐standard approach for modeling pharmacokinetic mediated drug–drug interactions is ...
© 2022 by the authors.Pharmacometrics is a multidisciplinary field utilizing mathematical models of ...
Abstract We developed a method to apply artificial neural networks (ANNs) for predicting time‐series...
This work presents a pharmacodynamic population analysis in chronic renal failure patients using Art...
The application of machine learning (ML) has shown promising results in precision medicine due to it...
Background: The dose individualization by therapeutic drug monitoring (TDM) can be improved if popul...
Objective: Metabolic syndrome (MetS) is an important side effect of second-generation anti-psychotic...